AR005896A1 - Compuestos n-metil-n-(4-(4-(1h-bencimidazol-2-il-amino)pipiridin-1-il)-2- (aril)butil) benzamidas sustituidos utiles para el tratamiento deenfermedades alergicas y composiciones con dichos compuestos. - Google Patents

Compuestos n-metil-n-(4-(4-(1h-bencimidazol-2-il-amino)pipiridin-1-il)-2- (aril)butil) benzamidas sustituidos utiles para el tratamiento deenfermedades alergicas y composiciones con dichos compuestos.

Info

Publication number
AR005896A1
AR005896A1 ARP970100645A ARP970100645A AR005896A1 AR 005896 A1 AR005896 A1 AR 005896A1 AR P970100645 A ARP970100645 A AR P970100645A AR P970100645 A ARP970100645 A AR P970100645A AR 005896 A1 AR005896 A1 AR 005896A1
Authority
AR
Argentina
Prior art keywords
compounds
amino
methyl
treatment
pipiridin
Prior art date
Application number
ARP970100645A
Other languages
English (en)
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/778,996 external-priority patent/US5922737A/en
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of AR005896A1 publication Critical patent/AR005896A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describen compuestos N-metil-N-(4-(4-(1H-bencimidazol-2-il-amino) pipiridin-1-il)-2-(aril)benzamidas de fórmula (I) y composiciones farmacéuticasque incluyen dichos compuestos. También se describe su utilización como antagonistasde los receptores de histamina y antagonistas de los receptores detaquiquininas, tales antagonistas son útiles en el tratamiento del asma; bronquitis; enfermedades inflamatorias del intestino, incluyendo la enfermedadde Crohn y la colitisulcera tiva; la rinitis alérgica, incluyendo la rinitis estacional y la sinusitis; las alergias; y la emesis.
ARP970100645A 1996-02-21 1997-02-19 Compuestos n-metil-n-(4-(4-(1h-bencimidazol-2-il-amino)pipiridin-1-il)-2- (aril)butil) benzamidas sustituidos utiles para el tratamiento deenfermedades alergicas y composiciones con dichos compuestos. AR005896A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60421696A 1996-02-21 1996-02-21
US08/778,996 US5922737A (en) 1996-02-21 1997-01-06 Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases

Publications (1)

Publication Number Publication Date
AR005896A1 true AR005896A1 (es) 1999-07-21

Family

ID=27084615

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970100645A AR005896A1 (es) 1996-02-21 1997-02-19 Compuestos n-metil-n-(4-(4-(1h-bencimidazol-2-il-amino)pipiridin-1-il)-2- (aril)butil) benzamidas sustituidos utiles para el tratamiento deenfermedades alergicas y composiciones con dichos compuestos.

Country Status (20)

Country Link
EP (1) EP0888336B1 (es)
JP (1) JP2001504798A (es)
KR (1) KR19990087131A (es)
CN (1) CN1115341C (es)
AR (1) AR005896A1 (es)
AT (1) ATE221882T1 (es)
AU (1) AU710488B2 (es)
BR (1) BR9707652A (es)
CA (1) CA2247105C (es)
DE (1) DE69714579T2 (es)
DK (1) DK0888336T3 (es)
ES (1) ES2176687T3 (es)
HK (1) HK1019734A1 (es)
HU (1) HUP9901030A3 (es)
IL (1) IL125578A (es)
NO (1) NO983830L (es)
NZ (1) NZ330908A (es)
PT (1) PT888336E (es)
TW (1) TW562804B (es)
WO (1) WO1997030989A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
GB0315203D0 (en) * 2003-06-28 2003-08-06 Celltech R&D Ltd Chemical compounds
CA2676357A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
JPH10504580A (ja) * 1994-08-25 1998-05-06 メレルファーマスーティカルズ インコーポレイテッド アレルギー病の処置に有用な新規な置換ピペリジン類

Also Published As

Publication number Publication date
DE69714579D1 (de) 2002-09-12
DE69714579T2 (de) 2003-04-10
AU2251997A (en) 1997-09-10
TW562804B (en) 2003-11-21
HUP9901030A2 (hu) 1999-07-28
NZ330908A (en) 2001-04-27
WO1997030989A1 (en) 1997-08-28
BR9707652A (pt) 1999-07-27
ATE221882T1 (de) 2002-08-15
CN1211246A (zh) 1999-03-17
NO983830L (no) 1998-10-20
HK1019734A1 (en) 2000-02-25
JP2001504798A (ja) 2001-04-10
IL125578A (en) 2002-09-12
IL125578A0 (en) 1999-03-12
HUP9901030A3 (en) 2002-01-28
DK0888336T3 (da) 2002-12-02
CN1115341C (zh) 2003-07-23
CA2247105C (en) 2002-05-14
EP0888336A1 (en) 1999-01-07
KR19990087131A (ko) 1999-12-15
CA2247105A1 (en) 1997-08-28
PT888336E (pt) 2002-12-31
EP0888336B1 (en) 2002-08-07
ES2176687T3 (es) 2002-12-01
NO983830D0 (no) 1998-08-20
AU710488B2 (en) 1999-09-23

Similar Documents

Publication Publication Date Title
FI970771A (fi) Uusia allergisten sairauksien hoidossa käyttökelpoisia substituoituja piperidiinejä
ECSP045367A (es) "derivados de bencimidazol utiles como antagonistas de histamina h3"
ES2184794T3 (es) Profarmacos de morfolina como antagonistas de receptores de taquicininas.
ATE250577T1 (de) Indolderivate und ihre verwendung als mcp-1 rezeptor antagonisten
CO5390086A1 (es) Derivados benzimidazol y piridilimidazol como ligandos para gabaa
PT1513826E (pt) Novos derivados de indolilpiperidina como agentes anti-histaminicos e antialergicos potentes
MX9300977A (es) Compuetos heterobiciclicos.
PE20050036A1 (es) COMPUESTOS DE FENIL-AZA-BENZIMIDAZOL PARA MODULAR LA IgE E INHIBIR LA PROLIFERACION CELULAR
ES2119174T3 (es) Azaciclos espiro-sustituidos como antagonistas de los receptores de las taquiquininas.
AR047439A1 (es) Antagonistas del receptor hidroisoindolina taquiquinina
ES2188801T3 (es) 4-(1h-bencimidazol-2-yl-amino) piperidinas sustituidas utiles para el tratamiento de enfermedades alergicas.
AR041942A1 (es) Derivados de 10-oxa -1-aza-dibenzo [a,d] ciclohepteno-7-carboxilico como antagonistas ccr1 para el tratamiento de la enfermedad desmielinizante inflamatoria
AR005896A1 (es) Compuestos n-metil-n-(4-(4-(1h-bencimidazol-2-il-amino)pipiridin-1-il)-2- (aril)butil) benzamidas sustituidos utiles para el tratamiento deenfermedades alergicas y composiciones con dichos compuestos.
ES2177827T3 (es) 4-(1h-bencimidazol-2-il)(1,4)diazepanes utiles para el tratamiento de enfermedades alergicas.
AR024840A1 (es) Compuestos de 5ht1 para terapia antidepresiva; composiciones farmaceuticas y su uso en la preparacion de medicamentos.
PT882038E (pt) N-metil-n-(4-(piperidin-1-il)-2-(aril)butil)benzamidas substituidas vantajosas para o tratamento de doencas alergicas
PT1497292E (pt) Derivados de azaindolilpiperidina como agentes anti-histaminicos e antialergicos
AR005897A1 (es) Derivados de n-metil-n-(4-(4-(1h-bencimidazol-2-il)[1,4]-diazepan-1-il)-2- (aril)butil)benzamidas utiles como antagonistas del receptor de histamina yantagonistas del receptor de taquiquininas y composicion farmaceutica conteniendolos.
ES2138366T3 (es) Indol carbamatos como antagonistas de leucotrienos.
AR005895A1 (es) Derivados de n-metil-n-(4-(piperidin-1-il)-2-(aril)butil)benzamida sustituida, utiles como antagonistas de los receptores de histamina yantagonista de los receptores de taquiquininas y composicion farmaceutica que los contiene.
UY26875A1 (es) Compuestos de 1,4-dihidropiridina como antagonistas de bradicinina
ES2150848B1 (es) Heterociclos metiloxinaftil sustituidos con accion antagonista de los leucotrienos.
ECSP972326A (es) Derivados de espiro - piperidina y su uso como agentes terapeuticos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal